Skip to main content
. 2021 Aug 6;42(6):1015–1025. doi: 10.1007/s00296-021-04955-8

Fig. 3.

Fig. 3

BASDAI values of AS patients using adalimumab. Left, the mean BASDAI values of patients with no ADAb. Right: The black dots show individual BASDAI values of ADAb-positive patients as a function of ADAb concentration